Lifeboat Foundation

A common concern in the community is that the FDA, the EMA, and other bodies, such as WHO, do not classify aging as a disease and that this poses a problem for developing therapies that target aging. However, this is not really as serious an issue as some people would suggest; today, we will have a look at why that is.

Why this will not stop progress

Aging is a variety of distinct processes, damages, and errors; therefore, simply treating aging in clinical terms is not a viable endpoint. For a clinical trial to be conducted, it requires a verifiable indication, and aging is too general for the FDA and EMA to classify it as a disease.

Continue reading “Not classing aging as a disease is not a major problem” »

https://paper.li/e-1437691924#/

In a newly released report, an influential UK ethics council concludes that editing human embryos is “morally permissible.”

But even though money is necessary, it’s not sufficient to provide human beings a sense of satisfaction, Obama cautioned. As more and more tasks and services become automated with the rise of artificial intelligence, “that’s going to make the job of giving everybody work that is meaningful tougher, and we’re going to have to be more imaginative, and the pace of change is going to require us to do more fundamental re-imagining of our social and political arrangements, to protect the economic security and the dignity that comes with a job.”

The former president says “we’re going to have to consider new ways of thinking” as technology threatens current labor markets.

Cancer and rodent studies were on the crew’s timeline today to help doctors and scientists improve the health of humans in space and on Earth. The crew also conducted an emergency drill aboard the International Space Station.

Flight Engineer Serena Auñón-Chancellor examined endothelial cells through a microscope for the AngieX Cancer Therapy study. The new cancer research seeks to test a safer, more effective treatment that targets tumor cells and blood vessels. Commander Drew Feustel partnered with astronaut Alexander Gerst and checked on mice being observed for the Rodent Research-7 (RR-7) experiment. RR-7 is exploring how microgravity impacts microbes living inside organisms.

Astronaut Ricky Arnold and Gerst collected and stowed their blood samples for a pair of ongoing human research studies. Arnold went on to work a series of student investigations dubbed NanoRacks Module-9 exploring a variety of topics including botany, biology and physics.

Continue reading “Mid-week Cancer Study and Emergency Drill Fill Station Schedule” »

Mankind is about to get closer to the sun than ever before.

Jupiter already had the most moons in the solar system — but they just found another dozen.

This Blue Origin rocket went higher than any previous rocket launched by Jeff Bezos’s company.

Our Fast Lightweight Autonomy program recently completed Phase 2 flight tests, demonstrating advanced algorithms designed to turn small air and ground systems into team members that can autonomously perform tasks dangerous for humans — such as pre-mission reconnaissance in a hostile urban setting or searching damaged structures for survivors following an earthquake.

Friends, I’m super excited to announce I’m launching a new #transhumanism column at The Maven, a new site out that features leaders in their field writing about their lives and activities. My column (or channel as The Maven editors call them) is titled: Transhumanist Wager. And I’ll be posting every day on it, often with original stories. Here’s my first one, just out! Give it a read!

Transhumanism—the social movement of merging people with machines & synthetic parts—is turning dangerously hard left.